Skip to main content

Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes

  • Chapter
  • First Online:
Myelin

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1190))

Abstract

Pelizaeus-Merzbacher disease (PMD) represents a group of disorders known as hypomyelinating leukodystrophies, which are characterized by abnormal development and maintenance of myelin in the central nervous system. PMD is caused by different types of mutations in the proteolipid protein 1 (PLP1) gene, which encodes a major myelin membrane lipoprotein. These mutations in the PLP1 gene result in distinct cellular and molecular pathologies and a spectrum of clinical phenotypes. In this chapter, I discuss the historical aspects and current understanding of the mechanisms underlying how different PLP1 mutations disrupt the normal process of myelination and result in PMD and other disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Anderson TJ, Schneider A, Barrie JA, Klugmann M, Mcculloch MC, Kirkham D, Kyriakides E, Nave KA, Griffiths IR (1998) Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene. J Comp Neurol 394:506–519

    Article  CAS  PubMed  Google Scholar 

  • Beck CR, Carvalho CMB, Banser L, Gambin T, Stubbolo D, Yuan B, Sperle K, Mccahan SM, Henneke M, Seeman P, Garbern JY, Hobson GM, Lupski JR (2015) Complex genomic rearrangements at the PLP1 locus include triplication and quadruplication. PLoS Genet 11:e1005050

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Boespflug-Tanguy O, Mimault C, Melki J, Cavagna A, Giraud G, Pham Dinh D, Dastugue B, Dautigny A, Group TPC (1994) Genetic homogeneity of Pelizaeus-Merzbacher disease: tight linkage to the proteolipoprotein locus in 16 affected families. Am J Hum Genet 55:461–467

    CAS  PubMed  PubMed Central  Google Scholar 

  • Boison D, Stoffel W (1994) Disruption of the compacted myelin sheath of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci U S A 91:11709–11713

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Boison D, Bussow H, D'urso D, Müller HW, Stoffel W (1995) Adhesive properties of proteolipid protein are responsible for the compaction of CNS myelin sheaths. J Neurosci 15:5502–5513

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R (2010) The burden of inherited leukodystrophies in children. Neurology 75:718–725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cailloux F, Gauthier-Barichard F, Mimault C, Isabelle V, Courtois V, Giraud G, Dastugue B, Boespflug-Tanguy O, Clinical Europian Network on Brain Dysmyelinating Disease (2000) Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Eur J Hum Genet 8:837–845

    Article  CAS  PubMed  Google Scholar 

  • Carvalho CMB, Lupski JR (2016) Mechanisms underlying structural variant formation in genomic disorders. Nat Rev Genet 17:224–238

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clark K, Sakowski L, Sperle K, Banser L, Landel CP, Bessert DA, Skoff RP, Hobson GM (2013) Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication. J Neurosci 33:11788–11799

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Clayton BL, Popko B (2016) Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia. Brain Res 1648:594–602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cremers FPM, Pfeiffer RA, Van De Pol TJR, Hofker MH, Kruse TA, Wieringa B, Ropers HH (1987) An interstitial duplication of the X chromosome in a male allows physical fine mapping of probes from the Xq13-q22 region. Hum Genet 77:23–27

    Article  CAS  PubMed  Google Scholar 

  • Dautigny A, Mattei M-G, Morello D, Alliel PM, Pham-Dinh D, Amar L, Arnaud D, Simon D, Mattei J-F, Guenet J-L, Jollès P, Avner P (1986) The structural gene coding for myelin-associated proteolipid protein is mutated in jimpy mice. Nature 321:867–869

    Article  CAS  PubMed  Google Scholar 

  • Ellis D, Malcolm S (1994) Proteolipid protein gene dosage effect in Pelizaeus-Merzbacher disease. Nat Genet 6:333–334

    Article  CAS  PubMed  Google Scholar 

  • Garbern JY, Cambi F, Tang X-M, Sima AA, Vallat JM, Bosch EP, Lewis R, Shy M, Sohi J, Kraft G, Chen KL, Joshi I, Leonard DG, Johnson W, Raskind W, Dlouhy SR, Pratt V, Hodes ME, Bird T, Kamholz J (1997) Proteolipid protein is necessary in peripheral as well as central myelin. Neuron 19:205–218

    Article  CAS  PubMed  Google Scholar 

  • Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, Van Der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR (2002) Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551–561

    Article  PubMed  Google Scholar 

  • Gencic S, Hudson LD (1990) Conservative amino acid substitution in the myelin proteolipid protein of jimpymsd mice. J Neurosci 10:117–124

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gow A, Lazzarini RA (1996) A cellular mechanism governing the severity of Pelizaeus-Merzbacher disease. Nat Genet 13:422–428

    Article  CAS  PubMed  Google Scholar 

  • Griffiths IR, Dickinson P, Montague P (1995) Expression of the proteolipid protein gene in glial cells of the post-natal peripheral nervous system of rodents. Neuropathol Appl Neurobiol 21:97–110

    Article  CAS  PubMed  Google Scholar 

  • Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, Mcculloch M, Nadon N, Nave KA (1998) Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610–1613

    Article  CAS  PubMed  Google Scholar 

  • Hastings PJ, Ira G, Lupski JR (2009) A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 5:e1000327

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hobson GM, Davis AP, Stowell NC, Kolodny EH, Sistermans EA, De Coo IF, Funanage VL, Marks HG (2000) Mutations in noncoding regions of the proteolipid protein gene in Pelizaeus-Merzbacher disease. Neurology 55:1089–1096

    Article  CAS  PubMed  Google Scholar 

  • Hobson GM, Huang Z, Sperle K, Stabley DL, Marks HG, Cambi F (2002) A PLP splicing abnormality is associated with an unusual presentation of PMD. Ann Neurol 52:477–488

    Article  CAS  PubMed  Google Scholar 

  • Hubner CA, Orth U, Senning A, Steglich C, Kohlschutter A, Korinthenberg R, Gal A (2005) Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease. Hum Mutat 25:321–322

    Article  PubMed  Google Scholar 

  • Hudson LD, Puckett C, Berndt J, Chan J, Gencic S (1989) Mutation of the proteolipid protein gene PLP in a human X chromosome-linked myelin disorder. Proc Natl Acad Sci U S A 86:8128–8131

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Ikenaka K, Kagawa T, Mikoshiba K (1992) Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells. J Neurochem 58:2248–2253

    Article  CAS  PubMed  Google Scholar 

  • Inoue K (2005) PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics 6:1–16

    Article  CAS  PubMed  Google Scholar 

  • Inoue K (2017) Cellular pathology of Pelizaeus-Merzbacher disease involving chaperones associated with endoplasmic reticulum stress. Front Mol Biosci 4:7

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Inoue K, Lupski JR (2002) Molecular mechanisms for genomic disorders. Annu Rev Genomics Hum Genet 3:199–242

    Article  CAS  PubMed  Google Scholar 

  • Inoue K, Osaka H, Sugiyama N, Kawanishi C, Onishi H, Nezu A, Kimura K, Kimura S, Yamada Y, Kosaka K (1996a) A duplicated PLP gene causing Pelizaeus-Merzbacher disease detected by comparative multiplex PCR. Am J Hum Genet 59:32–39

    CAS  PubMed  PubMed Central  Google Scholar 

  • Inoue Y, Kagawa T, Matsumura Y, Ikenaka K, Mikoshiba K (1996b) Cell death of oligodendrocytes or demyelination induced by overexpression of proteolipid protein depending on expressed gene dosage. Neurosci Res 25:161–172

    Article  CAS  PubMed  Google Scholar 

  • Inoue K, Osaka H, Imaizumi K, Nezu A, Takanashi J, Arii J, Murayama K, Ono J, Kikawa Y, Mito T, Shaffer LG, Lupski JR (1999) Proteolipid protein gene duplications causing Pelizaeus-Merzbacher disease: molecular mechanism and phenotypic manifestations. Ann Neurol 45:624–632

    Article  CAS  PubMed  Google Scholar 

  • Inoue K, Osaka H, Thurston VC, Clarke JT, Yoneyama A, Rosenbarker L, Bird TD, Hodes ME, Shaffer LG, Lupski JR (2002) Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet 71:838–853

    Article  PubMed  PubMed Central  Google Scholar 

  • Jung M, Sommer I, Schachner M, Nave KA (1996) Monoclonal antibody O10 defines a conformationally sensitive cell-surface epitope of proteolipid protein (PLP): evidence that PLP misfolding underlies dysmyelination in mutant mice. J Neurosci 16:7920–7929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Jurevics H, Hostettler J, Sammond DW, Nave KA, Toews AD, Morell P (2003) Normal metabolism but different physical properties of myelin from mice deficient in proteolipid protein. J Neurosci Res 71:826–834

    Article  CAS  PubMed  Google Scholar 

  • Kagawa T, Ikenaka K, Inoue Y, Kuriyama S, Tsujii T, Nakao J, Nakajima K, Aruga J, Okano H, Mikoshiba K (1994) Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene. Neuron 13:427–442

    Article  CAS  PubMed  Google Scholar 

  • Kevelam SH, Taube JR, Van Spaendonk RML, Bertini E, Sperle K, Tarnopolsky M, Tonduti D, Valente EM, Travaglini L, Sistermans EA, Bernard G, Catsman-Berrevoets CE, Van Karnebeek CDM, Ostergaard JR, Friederich RL, Elsaid MF, Schieving JH, Tarailo-Graovac M, Orcesi S, Steenweg ME, Van Berkel CGM, Waisfisz Q, Abbink TEM, Van Der Knaap MS, Hobson GM, Wolf NI (2015) Altered PLP1 splicing causes hypomyelination of early myelinating structures. Ann Clin Transl Neurol 2:648–661

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Khajavi M, Inoue K, Lupski JR (2006) Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet 14:1074–1081

    Article  CAS  PubMed  Google Scholar 

  • Klugmann M, Schwab MH, Puhlhofer A, Schneider A, Zimmermann F, Griffiths IR, Nave KA (1997) Assembly of CNS myelin in the absence of proteolipid protein. Neuron 18:59–70

    Article  CAS  PubMed  Google Scholar 

  • Lassuthova P, Zaliova M, Inoue K, Haberlova J, Sixtova K, Sakmaryova I, Paderova K, Mazanec R, Zamecnik J, Siskova D, Garbern J, Seeman P (2013) Three new PLP1 splicing mutations demonstrate pathogenic and phenotypic diversity of Pelizaeus-Merzbacher disease. J Child Neurol 29(7):924–931

    Article  PubMed  Google Scholar 

  • Lee JA, Inoue K, Cheung SW, Shaw CA, Stankiewicz P, Lupski JR (2006) Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease. Hum Mol Genet 15:2250–2265

    Article  CAS  PubMed  Google Scholar 

  • Lee JA, Carvalho CM, Lupski JR (2007) A DNA replication mechanism for generating nonrecurrent rearrangements associated with genomic disorders. Cell 131:1235–1247

    Article  CAS  PubMed  Google Scholar 

  • Li H, Okada H, Suzuki S, Sakai K, Izumi H, Matsushima Y, Ichinohe N, Goto YI, Okada T, Inoue K (2019) Gene suppressing therapy for Pelizaeus-Merzbacher disease using artificial microRNA. JCI Insight 4(10). pii:125052. https://doi.org/10.1172/jci.insight.125052

  • Lin JH, Li H, Yasumura D, Cohen HR, Zhang C, Panning B, Shokat KM, Lavail MM, Walter P (2007) IRE1 signaling affects cell fate during the unfolded protein response. Science 318:944–949

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu PF, Carvalho CMB, Hastings PJ, Lupski JR (2012) Mechanisms for recurrent and complex human genomic rearrangements. Curr Opin Genet Dev 22:211–220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lupski JR (1998) Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14:417–422

    Article  CAS  PubMed  Google Scholar 

  • Merzbacher L (1910) Eine eigenartige familiäre-hereditäre Erkrankungsform (Aplasia axialis extracorticalis congenita). Z Ges Neurol Psychiatr 3:1–138

    Article  Google Scholar 

  • Miller MJ, Haxhiu MA, Georgiadis P, Gudz TI, Kangas CD, Macklin WB (2003) Proteolipid protein gene mutation induces altered ventilatory response to hypoxia in the myelin-deficient rat. J Neurosci 23:2265–2273

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mimault C, Giraud G, Courtois V, Cailloux F, Boire JY, Dastugue B, Boespflug-Tanguy O, The Clinical European Network on Brain Dysmyelinating Disease (1999) Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. Am J Hum Genet 65:360–369

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nadon NL, Duncan ID, Hudson LD (1990) A point mutation in the proteolipid protein gene of the ‘shaking pup’ interrupts oligodendrocyte development. Development 110:529–537

    CAS  PubMed  Google Scholar 

  • Nave KA, Lai C, Bloom FE, Milner RJ (1987) Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci U S A 84:5665–5669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nave KA, Lai C, Bloom F, Milner RJ (1989) Jimpy mutant mouse: a 74-base deletion in the mRNA for myelin proteolipid protein and evidence for a primary defect in mRNA splicing. Proc Natl Acad Sci U S A 83:9264–9268

    Article  Google Scholar 

  • Nevin ZS, Factor DC, Karl RT, Douvaras P, Laukka J, Windrem MS, Goldman SA, Fossati V, Hobson GM, Tesar PJ (2017) Modeling the mutational and phenotypic landscapes of Pelizaeus-Merzbacher disease with human iPSC-derived oligodendrocytes. Am J Hum Genet 100:617–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Numata Y, Morimura T, Nakamura S, Hirano E, Kure S, Goto YI, Inoue K (2013) Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the Golgi apparatus associated with pathogenesis in Pelizaeus-Merzbacher disease. J Biol Chem 288:7451–7466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Numata Y, Gotoh L, Iwaki A, Kurosawa K, Takanashi J, Deguchi K, Yamamoto T, Osaka H, Inoue K (2014) Epidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies. J Neurol 261:752–758

    Article  PubMed  Google Scholar 

  • Osaka H, Kawanishi C, Inoue K, Uesugi H, Hiroshi K, Nishiyama K, Yamada Y, Suzuki K, Kimura S, Kosaka K (1995) Novel nonsense proteolipid protein gene mutation as a cause of X-linked spastic paraplegia in twin males. Biochem Biophys Res Commun 215:835–841

    Article  CAS  PubMed  Google Scholar 

  • Osorio MJ, Rowitch DH, Tesar P, Wernig M, Windrem MS, Goldman SA (2017) Concise review: stem cell-based treatment of Pelizaeus-Merzbacher disease. Stem Cells 35:311–315

    Article  PubMed  Google Scholar 

  • Pelizaeus F (1885) Über eine eigentümliche Form spastischer Lähmung mit cerebral Erscheinungen auf hereditärer Grundlage (multiple Sklerose). Arch Psychiatr Nervenkr 16:698–710

    Article  Google Scholar 

  • Pouwels PJW, Vanderver A, Bernard G, Wolf NI, Dreha-Kulczewksi SF, Deoni SCL, Bertini E, Kohlschutter A, Richardson W, Ffrench-Constant C, Kohler W, Rowitch D, Barkovich AJ (2014) Hypomyelinating leukodystrophies: translational research progress and prospects. Ann Neurol 76:5–19

    Article  PubMed  Google Scholar 

  • Raskind WH, Williams CA, Hudson LD, Bird TD (1991) Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Hum Genet 49:1355–1360

    CAS  PubMed  PubMed Central  Google Scholar 

  • Readhead C, Schneider A, Griffiths I, Nave KA (1994) Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage. Neuron 12:583–595

    Article  CAS  PubMed  Google Scholar 

  • Rosenbluth J, Nave KA, Mierzwa A, Schiff R (2006) Subtle myelin defects in PLP-null mice. Glia 54:172–182

    Article  PubMed  Google Scholar 

  • Saugier-Veber P, Munnich A, Bonneau D, Rozet JM, Le Merrer M, Gil R, Boespflug-Tanguy O (1994) X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet 6:257–262

    Article  CAS  PubMed  Google Scholar 

  • Schneider A, Montague P, Griffiths I, Fanarraga M, Kennedy P, Brophy P, Nave K-A (1992) Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene. Nature 358:758–761

    Article  CAS  PubMed  Google Scholar 

  • Schneider AM, Griffiths IR, Readhead C, Nave KA (1995) Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein. Proc Natl Acad Sci U S A 92:4447–4451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Schroder M, Kaufman RJ (2005) The mammalian unfolded protein response. Annu Rev Biochem 74:739–789

    Article  PubMed  CAS  Google Scholar 

  • Seitelberger F (1970) Pelizaeus-Merzbacher disease. In: Vinken P, Bruyn G (eds) Handbook of clinical neurology. Leucodystrophies and poliodystrophies. North-Holland, Amsterdam

    Google Scholar 

  • Seitelberger F (1995) Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol 5:267–273

    Article  CAS  PubMed  Google Scholar 

  • Shy ME, Hobson G, Jain M, Boespflug-Tanguy O, Garbern J, Sperle K, Li W, Gow A, Rodriguez D, Bertini E, Mancias P, Krajewski K, Lewis R, Kamholz J (2003) Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol 53:354–365

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Simons M, Kramer EM, Macchi P, Rathke-Hartlieb S, Trotter J, Nave KA, Schulz JB (2002) Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol 157:327–336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Southwood CM, Garbern J, Jiang W, Gow A (2002) The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585–596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steenweg ME, Wolf NI, Schieving JH, Elsaid MF, Friederich RL, Ostergaard JR, Barkhof F, Pouwels PJW, Van Der Knaap MS (2012) Novel hypomyelinating leukoencephalopathy affecting early myelinating structures. Arch Neurol 69:125–128

    Article  PubMed  Google Scholar 

  • Swanton E, Holland A, High S, Woodman P (2005) Disease-associated mutations cause premature oligomerization of myelin proteolipid protein in the endoplasmic reticulum. Proc Natl Acad Sci U S A 102:4342–4347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880–885

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Taube JR, Sperle K, Banser L, Seeman P, Cavan BC, Garbern JY, Hobson GM (2014) PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing. Hum Mol Genet 23:5464–5478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Trofatter JA, Dlouhy SR, Demyer W, Conneally PM, Hodes ME (1989) Pelizaeus-Merzbacher disease: tight linkage to proteolipid protein gene exon variant. Proc Natl Acad Sci U S A 86:9427–9430

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Vanderver A, Tonduti D, Schiffmann R, Schmidt J, Van Der Knaap MS (2014) Leukodystrophy overview. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (eds) GeneReviews((R)). University of Washington, Seattle, WA

    Google Scholar 

  • Vanderver A, Prust M, Tonduti D, Mochel F, Hussey HM, Helman G, Garbern J, Eichler F, Labauge P, Aubourg P, Rodriguez D, Patterson MC, Van Hove JL, Schmidt J, Wolf NI, Boespflug-Tanguy O, Schiffmann R, Van Der Knaap MS, Consortium G (2015) Case definition and classification of leukodystrophies and leukoencephalopathies. Mol Genet Metab 114:494–500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Weimbs T, Stoffel W (1992) Proteolipid protein (PLP) of CNS myelin: positions of free, disulfide-bonded, and fatty acid thioester-linked cysteine residues and implications for the membrane topology of PLP. Biochemistry 31:12289–12296

    Article  CAS  PubMed  Google Scholar 

  • Willard HF, Riordan JR (1985) Assignment of the gene for myelin proteolipid protein to the X chromosome: implications for X-linked myelin disorders. Science 230:940–942

    Article  CAS  PubMed  Google Scholar 

  • Wolf NI, Sistermans EA, Cundall M, Hobson GM, Davis-Williams AP, Palmer R, Stubbs P, Davies S, Endziniene M, Wu Y, Chong WK, Malcolm S, Surtees R, Garbern JY, Woodward KJ (2005) Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain 128:743–751

    Article  PubMed  Google Scholar 

  • Woodward K, Kendall E, Vetrie D, Malcolm S (1998) Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH. Am J Hum Genet 63:207–217

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ken Inoue .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Inoue, K. (2019). Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes. In: Sango, K., Yamauchi, J., Ogata, T., Susuki, K. (eds) Myelin. Advances in Experimental Medicine and Biology, vol 1190. Springer, Singapore. https://doi.org/10.1007/978-981-32-9636-7_13

Download citation

Publish with us

Policies and ethics